The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action. | AHRQ Patient Safety Network

The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action. | AHRQ Patient Safety Network

• Review
 
• Published March 2016

The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action.

Reed BN, Fox ER, Konig M, et al. Am Heart J. 2016;175:130-141.

Patients hospitalized with cardiovascular conditions are particularly vulnerable to medication errors. This review explains how drug shortages associated with cardiovascular medications pose risks to patients and provides recommendations for clinicians, policymakers, and manufacturers to address this problem.

Available at

Related Resources

MEETING/CONFERENCE › NEW YORK MEETING/CONFERENCE

Medication Safety Symposium.

PULSE of New York. April 18, 2016; Holiday Inn, Plainview, NY.

NEWSPAPER/MAGAZINE ARTICLE

Government and industry fail to protect the public when they suggest "carefully following instructions" is enough to prevent vaccine errors.

ISMP Medication Safety Alert! Acute Care Edition. February 25, 2016;21:1-5.

JOURNAL ARTICLE › REVIEW

Improving patient safety through simulation training in anesthesiology: where are we?

Green M, Tariq R, Green P. Anesthesiol Res Pract. 2016 Feb 1; [Epub ahead of print].

JOURNAL ARTICLE › COMMENTARY

Threats to safety during sedation outside of the operating room and the death of Michael Jackson.

Webster CS, Mason KP, Shafer SL. Curr Opin Anaesthesiol. 2016;29(suppl 1):S36-S47.

NEWSPAPER/MAGAZINE ARTICLE

Selected medication safety risks to manage in 2016 that might otherwise fall off the radar screen—part 1 and part 2.

ISMP Medication Safety Alert! Acute Care Edition. January 28, 2016;21:1-4. February 11, 2016;21:1-5.

View More